References

medalphabet

Медицинский алфавит

Medical alphabet

2078-56312949-2807

ООО «Альфмед»

medalphabet-426

Research Article

Статьи

Микробиологическая диагностика стрептококковых инфекций в условиях реальной практики

Microbiological diagnosis of streptococcal infections in real practice conditions

Евдокимова

Н. В.

Evdokimova

N. V.

noemail@neicon.ru

Черненькая

Т. В.

Chernenkaya

T. V.

noemail@neicon.ru

ГБУЗ г. Москвы «Научно-исследовательский институт скорой помощи имени Н. В. Склифосовского» Департамента здравоохраненияРоссияResearch Institute of Emergency Care n.a. N. V. SklifosovskyRussian Federation

2017

09122017

438

Эпидемиология и гигиена

2529

2017

Евдокимова Н.В., Черненькая Т.В.

Evdokimova N.V., Chernenkaya T.V.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.med-alphabet.com/jour/article/view/426

В обзоре представлены группы клинически значимых видов стрептококков, роль которых в реальной клинической практике недостаточно известна. Проведена оценка подходов, лежащих в основе современной фенотипической идентификации стрептококков. Рассмотрены возможные пути преодоления трудностей, связанных с идентификацией стрептококков и определением их антибиотикочувствительности.

In present review the groups of streptococci which are associated with human diseases were considered. Their clinical role is not sufficiently recognized by the medical community. Modern approaches to phenotypic identification of Streptococcus species were discussed. The possible ways of overcoming the difficulties of routine laboratory connected with microbiological diagnosis and antibiotic treatment of streptococcal infections were also discussed.

клинически значимые виды стрептококковфенотипическая идентификация стрептококковантибиотикотерапия стрептококковых инфекций

clinically important streptococciphenotypic identification of streptococciantibiotic therapy of streptococcal infections

References1

Thompson C. C., Emmel V. E., Fonseca E. L., Marin M. A., Vicente A. C. P. Streptococcal taxonomy based on genome sequence analyses. F1000 Reserach. 2013; 2: 67.

Murray PR. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: usefulness for taxonomy and epidemiology. Clin Microbiol Infect2010; 16: 1626-30.

Hoshino T., Fujiwara T., Kilian M. Use of phylogenetic and phenotypic analyses to identify nonhemolytic streptococci isolated from bacteremic patients. J Clin Microbiol 2005; 43 (12): 6073-85.

UK Standards for Microbiology Investigations. Identification of Streptococcus species, Enterococcus species and Morphologically Similar Organisms. Public Health England. Bacteriology - Identification 2014; ID4 Issue 3: 1-36.

Bacitracin/Sulfamethoxazole-Trimethopim (SXT) tests. In: MacFaddin J.F., editor. Biochemical Tests for Identification of Medical Bacteria. 3rd ed. Philadelphia: Lippincott, Williams and Wilkins; 2000: 3-7.

Kaufhold A., Ferrieri P. The microbiologic aspects, including diagnosis, of beta-hemolytic streptococcal and enterococcal infections. Infect Dis Clin North Am 1993; 7: 235-56.

Woo P. C., Fung A. M., Lau S. K., Wong S. S., Yuen K. Y. Group G beta-hemolytic streptococcal bacteremia characterized by 16S ribosomal RNA gene sequencing. J Clin Microbiol 2001; 39: 3147-55.

Kellogg J. A. Suitability of throat culture procedures for detection of group A streptococci and as reference standards for evaluation of streptococcal antigen detection kits. J Clin Microbiol 1990; 28: 165-9.

Jensen A., Kilian M. Delineation of Streptococcus dysgalactiae, its subspecies, and its clinical and phylogenetic relationship to Streptococcus pyogenes. J Clin Microbiol 2012; 50: 113-26.

Hashikawa S., Iinuma Y., Furushita M., Ohkura T., Nada T., Torii K., et al. Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol2004; 42: 186-92.

Bordes-Benitez A., Sanchez-Onoro M., Suarez-Bordön P., Garcia-Rojas A.J., Saez-Nieto J.A., Gonzalez-Garcia A., et al. Outbreak of Streptococcus equi subsp. zooepidemicus infections on the island of Gran Canaria associated with the consumption of inadequately pasteurized cheese. Eur J Clin Microbiol Infect Dis 2006; 25: 242-6.

Kuusi M., Lahti E., Virolainen A., Hatakka M., Vuento R., Rantala L., et al. An outbreak of Streptococcus equi subspecies zooepidemicus associated with consumption of fresh goat cheese. BMC Infect Dis 2006; 6: 36.

Rajasekhar A, Clancy CJ. Meningitis due to group C Streptococcus: a case report and review of the literature. Scand J Infect Dis 2010; 42: 571-8.

Pelkonen S., Lindahl S. B., Suomala P., Karhukorpi J., Vuorinen S., Koivula I., et al. Transmission of Streptococcus equi subspecies zooepidemicus infection from horses to humans. Emerg Infect Dis 2013; 19: 1041-8.

Galpärine T., Cazorla C., Blanchard E., Boineau F., Ragnaud Neau J.-M.D. Streptococcus canis infections in humans: retrospective study of 54 patients. J Infect 2007; 55: 23-6.

Ohtaki H., Ohkusu K., Ohta H., Miyazaki T., Yonetamari J.,-Usui T., et al. A case of sepsis caused by Streptococcus canis in a dog owner: a first case report of sepsis without dog bite in Japan. J Infect Chemother 2013; 19: 1206-9.

Lam M. M., Clarridge J. E. 3rd, Young E. J., Mizuki S. The other group G Streptococcus: increased detection of Streptococcus canis ulcer infections in dog owners. J Clin Microbiol 2007; 45: 2327-9.

The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0, 2015. URL: www.eucast.org.

Loubinoux J., PlainvertC., CollobertG, Touak G., Bouvet A., Poya C. Adult invasive and noninvasive infections due to Streptococcus dysgalactiae subsp. equisimilis in France from 2006 to 2010. J Clin Microbiol2013; 51:2724-7.

Biedenbach D. J., Toleman M. A., Walsh T. R., Jones R. N. Characterization of fluoroquinolone-resistant betahemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn Microbiol Infect Dis 2006; 55: 119-27.

Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 2002; 15: 613-30.

Friedrichs C., Rodloff A.C., Chhatwal G.S., Schellenberger W., Eschrich K. S. O. Rapid identification of viridans streptococci by mass spectrometric discrimination. J Clin Microbiol 2007; 45: 2392-7.

Brogan O., Malone J., Fox C., Whyte A. S. Lancefield grouping and smell of caramel for presumptive identification and assessment of pathogenicity in the Streptococcus milleri group. J Clin Pathol 1997; 50: 332-5.

Sibley C. D., Grinwis M. E., Field T. R., Parkins M. D., Norgaard J. C., Gregson D. B., et al. McKay agar enables routine quantification of the ‘Streptococcus milleri’ group in cystic fibrosis patients. J Med Microbiol 2010; 59 (Pt 5): 534-40.

Summanen P. H., Rowlinson M. C., Wooton J., Finegold S.M. Evaluation of genotypic and phenotypic methods for differentiation of the members of the Anginosus group streptococci. Eur J Clin Microbiol Infect Dis 2009; 28: 1123-8.

Hoshino T., Fujiwara T., Kilian M. Use of phylogenetic and phenotypic analyses to identify nonhemolytic streptococci isolated from bacteremic patients. J Clin Microbiol 2005; 43: 6073-85.

Broyles L. N., Van Beneden C., Beall B., Facklam R., Shewmaker P. L., Malpiedi P., et al. Population-based study of invasive disease due to betahemolytic streptococci of groups other than A and B. Clin Infect Dis 2009; 48: 706-12.

Hardwick R. H., Taylor A., Thompson M. H., Jones E., Roe A. M., et al. Association between Streptococcus milleri and abscess formation after appendicitis. Ann R CollSurg Engl 2000; 82: 24-6.

Petti C.A., Simmon K. E., Bender J., Blaschke A., Webster K.A., Conneely M.F., et al. Culture-Negative intracerebral abscesses in children and adolescents from Streptococcus anginosus group infection: a case series. Clin Infect Dis 2008; 46: 1578-80.

Kowlessar P. I., O’Connell N.H., Mitchell R.D., Elliott S., Elliott T. S. Management of patients with Streptococcus milleri brain abscesses. J Infect2006; 52 (6): 443-50.

Tracy M., Wanahita A., Shuhatovich Y., Goldsmith E. A., Clarridge J. E. 3rd, Musher D. M., et al. Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains. Antimicrob Agents Chemother 2001; 45: 1511-14.

Yamamoto N., Fujita J., Shinzato T., Higa F., Tateyama M., Tohyama M., et al. In vitro activity of sitafloxacin compared with sev

Медицинский алфавит №38 / 2017, том № 4. Эпидемиология и гигиена E-mail: medalfavit@mail.ru eral fluoroquinolones against Streptococcus anginosus and Streptococcus constellatus. Int J Antimicrob Agents 2006; 27 (2): 171-3.

Dutta C., Worley G., Bowdler D. Lemierre’s syndrome. Otorhinolaryngol Head Neck Surg. 2004; 8 (2): 53-5.

Asmah N., Eberspächer B., Regnath T., Arvand M. Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany. J Med Microbio 2009; 58 (Pt2): 222-7.

Limia A., Jimänez M. L, Alarcon T., Lopez-Brea M. Five-year analysis of antimicrobial susceptibility of the Streptococcus milleri group. Eur J Clin Microbiol Infect Dis 1999; 18: 440-4.

Park H. K., Myung S. C.and Kim W. Comparative transcriptomic analysis of Sreptococcus pseudopneumoniae with viridans group streptococci. BMC Microbiology2012, 12: 77.

Seki M., Yamashita Y., Torigoe H., Tsuda H., Sato S., Maeno M. Loop-mediated isothermal amplification method targeting the lytA gene for detection of Streptococcus pneumoniae. J Clin Microbiol2005; 43: 1581-6.

Verhelst R., Kaijalainen T., De Baere T., Verschraegen G., Claeys G., Van Simaey L., De Ganck C., Vaneechoutte M. Comparison of five genotypic techniques for identification of optochin-resistant pneumococcus-like isolates. J Clin Microbiol 2003; 41: 3521-5.

Doern G. V., Ferraro M. J., Brueggemann A. B., Ruoff K. L. Emergence of high rates of anti-microbial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 1996; 40: 891-4.

Renneberg J., Niemann L. L, Gutschik E., Antimicrobial susceptibility of 278 streptococcal blood isolates to seven antimicrobial agents. J Antimicrob Chemother 1997; 39: 135-40.

Konig A., Reinert R. R., Hakenbeck R. Streptococcus mitis with unusually high level resistance to beta-lactam antibiotics. Microb Drug Resist 1998; 4: 45-9.

Bancescu G., Dumitriu S., Bancescu A., Defta C., Pana M., lonescu D., et al. Susceptibility testing of Streptococcus mitis group isolates. Indian J Med Res 2004; 119 (Suppl): 257-61.

Johnson C. C., Tunkel A. R. Viridans streptococci, groups C and G streptococci. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennet. Principles and practice ofinfectious diseases. 6th ed. Philadelphia: Churchill Livingstone; 2005: 2434-51.

Levy C. S., Kogulan P., Gill V. J., Croxton M. B., Kane J. G., Lucey D. R. Endocarditis caused by penicillin-resistant viridians streptococci: 2 cases and controversies in therapy. Clin Infect Dis 2001; 33: 577-9.

Stock J. H., Sahn D. J. Endocarditis in the pediatric population. Curr Treat Options Cardiovasc Med 2000; 2: 481-8.

Davey A. L., Rogers A. H. Multiple types of the bacterium Streptococcus mutans in the human mouth and their intra-family transmission. Arch Oral Biol 1984; 29: 453-60.

Ajdic D., McShan W.M., McLaughlin R.E., Savic G., Chang J., Carson M. B., et al. Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. PNAS 2002; 99: 14434-9.

Ahmed R., Hassall T., Morland B., Gray J. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem. Pediatr Hematol Oncol. 2003; 20 (6): 439-44.

Conte A., Chinelo P., Civljak R., Bellucci A., Note P., Petrosillo, N. Streptococcus salivarius meningitis and sphenoid sinus mucocele. Case report and literature review. J Infection 2006; 52: e27-30.

Wishplinghoff H., Wenzel R., Seifert H., Edmond B. Current trends in the Epidemiology of Nosocomial bloodstream Infections in patients with Hematological malignancies and solid neoplasms in hospitals in United States. Clinical Infectious Diseases2003; 36: 1103-10.

Lee T. H., Hsueh P. R., Yeh W. C., Wang H. P., Wang T. H., Lin, J. T. Low frequency of bacteremia after endoscopic mucosal resection. Gastrointest Endosc 2000; 52: 223-5.

Gold J. S., Bayar S., Salem R. R. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg 2004; 139: 760-5.

Herrington C.S., McGee J.OD. Diagnostic molecular pathology: a practical approach. Oxford; New York: IRL Press at Oxford University Press; 1992.

Corredoira-Sänchez J, Garcia-Garrote F, Rabunal R, Lopez-Roses L, Garcfa-Pafs MJ, Castro E, et al. Association between bacteremia due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and colorectal neoplasia: a case-control study. Clin Infect Dis 2012; 55 (4): 491-6.

Gelfand M. S., Alford R. H. Streptococcus bovis endocarditis and squamouscell carcinoma of the mouth. N Engl J Med 1981; 305: 284-5.

Boleij A., Muytjens C. M., Bukhari S.I., Cayet, N., Glaser P., Hermans P. W. M., et al. Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. J Infect Dis 2011; 203: 1101-9.

Boleij A., Tjalsma H. The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease. Lancet Infect Dis 2013; 13: 719-24.

The authors declare that there are no conflicts of interest present.